We are live on ! Find out more
VMD icon

Viemed Healthcare

132 hedge funds and large institutions have $177M invested in Viemed Healthcare in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

7% more capital invested

Capital invested by funds: $166M → $177M (+$10.8M)

1% more funds holding

Funds holding: 131132 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 43

0.41% less ownership

Funds ownership: 63.09%62.69% (-0.41%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
132
Holders Change
+1
Holders Change %
+0.76%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
20
Increased
43
Reduced
43
Closed
14
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$34.4M -$975K -142,252 -3%
FCM
2
Forager Capital Management
Alabama
$20.7M +$338K +49,399 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$13.2M -$151K -21,975 -1%
Goldman Sachs
4
Goldman Sachs
New York
$10.8M +$342K +49,962 +4%
NCM
5
Nantahala Capital Management
Connecticut
$6.93M
Ameriprise
6
Ameriprise
Minnesota
$6.11M +$4.78M +697,866 +559%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$5.77M -$146K -21,285 -3%
State Street
8
State Street
Massachusetts
$5.02M +$78K +11,385 +2%
PAIM
9
Punch & Associates Investment Management
Minnesota
$4.99M
First Eagle Investment Management
10
First Eagle Investment Management
New York
$3.85M +$276K +40,313 +8%
TAM
11
Tocqueville Asset Management
New York
$3.51M +$171K +25,000 +6%
PAM
12
Panagora Asset Management
Massachusetts
$3.48M +$239K +34,811 +8%
Renaissance Technologies
13
Renaissance Technologies
New York
$3.28M -$42.5K -6,200 -1%
RA
14
Raffles Associates
New York
$3.1M
Arrowstreet Capital
15
Arrowstreet Capital
Massachusetts
$2.62M
BA
16
Bard Associates
Illinois
$2.52M -$11.3K -1,653 -0.5%
Morgan Stanley
17
Morgan Stanley
New York
$2.18M +$186K +27,206 +10%
SBH
18
Segall Bryant & Hamill
Illinois
$2.15M -$4.63K -675 -0.2%
PM
19
Penbrook Management
New York
$2.02M -$5.34K -780 -0.3%
Two Sigma Investments
20
Two Sigma Investments
New York
$1.94M +$70.6K +10,304 +4%
Qube Research & Technologies (QRT)
21
Qube Research & Technologies (QRT)
United Kingdom
$1.88M -$262K -38,288 -13%
Northern Trust
22
Northern Trust
Illinois
$1.85M -$153K -22,335 -8%
RHJA
23
Rice Hall James & Associates
California
$1.71M +$212K +30,981 +16%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$1.44M -$215K -31,325 -14%
EEL
25
Expect Equity LLC
Maryland
$1.29M +$445K +64,961 +60%

VMD Hedge Fund Activity: Q4 2025 in Review

132 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q4 2025, worth a combined $177M — up 6.5% from $166M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VMD positions and 14 closed out — a net gain of 6 holders — while 43 added to existing stakes and 43 trimmed.

The largest buyer was Ameriprise, adding an estimated $4.78M. The largest seller was Thrivent Financial for Lutherans, exiting entirely with an estimated $2.61M sold.

  • 132 institutional investors held Viemed Healthcare (VMD) as of Q4 2025, up from 131 in Q3 2025.
  • Funds reported $177M of Viemed Healthcare stock for Q4 2025, up 6.5% quarter-over-quarter.
  • 20 funds opened new Viemed Healthcare positions in Q4 2025 and 14 closed out, a net change of +6 holders.
  • The largest Viemed Healthcare buyer in Q4 2025 was Ameriprise, an estimated $4.78M added.
  • The largest Viemed Healthcare seller in Q4 2025 was Thrivent Financial for Lutherans, an estimated $2.61M sold.

Based on aggregated 13F filings for Q4 2025.